How big is Vanta Bioscience?

Jul 24 2025 06:18 PM IST
share
Share Via
As of 24th July, Vanta Bioscience Ltd has a market capitalization of 20.00 Cr and reported net sales of 3.45 Cr with a net profit loss of 3.92 Cr for the latest quarter ending March 2023. Shareholder's funds are 15.20 Cr, and total assets amount to 85.40 Cr as of March 2024.
As of 24th July,

Market Cap: Vanta Bioscience Ltd has a market capitalization of 20.00 Cr, categorizing it as a Micro Cap company.

Recent Quarterly Performance: For the latest quarter ending March 2023, Vanta Bioscience reported Net Sales of 3.45 Cr and a Net Profit loss of 3.92 Cr.

Balance Sheet Snapshot: The latest annual period reported is March 2024, with Shareholder's Funds amounting to 15.20 Cr and Total Assets of 85.40 Cr.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Vanta Bioscience overvalued or undervalued?
Aug 05 2025 08:03 AM IST
share
Share Via
When is the next results date for Vanta Bioscience?
Jul 30 2025 11:16 PM IST
share
Share Via